Source Natural

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE679C01027
NSEID:
BSEID: 531398

INR

180.00

-2.95 (-1.61%)

BSENSE

Apr 11, 12:49 PM

BSE+NSE Vol: 254

{
  "main_header": {
    "sid": 446660,
    "name": "Source Natural",
    "stock_name": "Source Natural",
    "full_name": "Source Natural Foods & Herbal Supplements Ltd",
    "name_url": "stocks-analysis/source-natural",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "180.00",
    "chg": -2.95,
    "chgp": "-1.61%",
    "dir": -1,
    "prev_price": "182.95",
    "mcapval": "120.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531398,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE679C01027",
    "curr_date": "Apr 11, 12:49 PM",
    "curr_time": "00:07 AM",
    "bse_nse_vol": "254 ",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/source-natural-446660-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Source Natural Foods Receives Quality Grade Upgrade Amid Strong Growth Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/source-natural-foods-upgraded-to-average-quality-grade-amid-strong-financial-metrics-1655784",
        "imagepath": "",
        "date": "2025-04-01 08:00:03",
        "description": "Source Natural Foods & Herbal Supplements has recently undergone an evaluation revision, reflecting its performance metrics within the pharmaceuticals and drugs industry. The company has demonstrated notable sales growth over the past five years, achieving a rate of 22.39%. Additionally, its EBIT growth during the same period stands at 27.03%, indicating a strong operational performance.\n\nFinancial stability is further highlighted by the company's average EBIT to interest ratio of 3.45 and a low debt to EBITDA ratio of 0.38, suggesting effective management of financial obligations. The net debt to equity ratio is also minimal at 0.03, showcasing a solid capital structure. Furthermore, the company's return on capital employed (ROCE) and return on equity (ROE) average at 20.17% and 17.97%, respectively, underscoring its efficient use of capital.\n\nIn comparison to its peers, Source Natural holds an average qua..."
      },
      {
        "title": "Source Natural Foods Faces Valuation Shift Amid Mixed Financial Indicators",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/source-natural-foods-downgraded-to-strong-sell-amid-valuation-concerns-1637107",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/SourceNaturalFo_mojoScore_830678.png",
        "date": "2025-03-28 08:04:38",
        "description": "Source Natural Foods & Herbal Supplements has recently adjusted its valuation metrics, reflecting a change in its market position within the Pharmaceuticals & Drugs industry. Key financial indicators, including a high price-to-earnings ratio and a notable return on equity, underscore the complexities of the company's financial landscape."
      },
      {
        "title": "Source Natural Foods Adjusts Valuation Amid Strong Performance in Pharmaceuticals Sector",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/source-natural-foods-herbal-supplements-sees-valuation-grade-shift-from-fair-to-expensive-1636912",
        "imagepath": "",
        "date": "2025-03-28 08:00:18",
        "description": "Source Natural Foods & Herbal Supplements has recently undergone a valuation adjustment, reflecting its current standing in the pharmaceuticals and drugs industry. The company, classified as a microcap, has reported a price-to-earnings (P/E) ratio of 45.10 and an enterprise value to EBITDA ratio of 21.49. These metrics indicate a premium valuation compared to some of its peers.\n\nIn terms of performance, Source Natural has shown notable returns over various periods. Over the past year, the stock has returned 105.51%, significantly outperforming the Sensex, which recorded a return of 6.32%. Additionally, the company has demonstrated strong financial health with a return on capital employed (ROCE) of 23.03% and a return on equity (ROE) of 12.62%.\n\nWhen compared to its peers, Source Natural's valuation metrics stand out, particularly against companies like Shukra Pharma, which has a much higher P/E ratio, and K..."
      },
      {
        "title": "Source Natural Foods Surges Nearly 20% Amid Strong Buying Activity and Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/source-natural-foods-herbal-supplements-ltd-surges-19-98-achieves-28-08-weekly-gain-1623230",
        "imagepath": "",
        "date": "2025-03-27 10:05:07",
        "description": "Source Natural Foods & Herbal Supplements Ltd is witnessing significant buying activity, with the stock surging 19.98% today, notably outperforming the Sensex, which gained only 0.45%. Over the past week, the stock has shown a remarkable increase of 28.08%, while the Sensex rose by 1.68%. This strong performance is part of a two-day consecutive gain, where the stock has returned 26.52%.\n\nThe stock opened with a notable gap up of 13.56% and reached an intraday high of Rs 183.15. In terms of longer-term performance, Source Natural Foods has delivered a staggering 105.51% return over the past year, compared to the Sensex's 6.35%. However, it is important to note that the stock has experienced a decline of 5.10% year-to-date, while the Sensex has decreased by only 0.65%.\n\nThe current buying pressure may be attributed to various factors, including market sentiment towards the pharmaceuticals and drugs sector, re..."
      },
      {
        "title": "Source Natural Foods Faces Evaluation Adjustment Amid Mixed Financial Performance Indicators",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/source-natural-foods-receives-sell-rating-amid-mixed-technical-indicators-1494982",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/SourceNaturalFo_mojoScore_723262.png",
        "date": "2025-03-20 08:05:52",
        "description": "Source Natural Foods & Herbal Supplements has recently experienced an evaluation adjustment due to changes in its technical indicators. The company, part of the Pharmaceuticals & Drugs sector, has shown strong financial metrics, including a high return on equity and low debt-to-equity ratio, despite facing recent profit challenges."
      },
      {
        "title": "Source Natural Foods Reports Positive Financials Amid Bearish Market Conditions",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/source-natural-foods-downgraded-to-strong-sell-amid-bearish-technical-indicators-1341459",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/SourceNaturalFo_mojoScore_661606.png",
        "date": "2025-03-13 08:06:10",
        "description": "Source Natural Foods & Herbal Supplements has adjusted its evaluation following positive third-quarter FY24-25 results, including increased cash reserves and net sales. The company maintains strong management efficiency, evidenced by a solid return on equity and low debt levels, despite a slight decline in profits over the past year."
      },
      {
        "title": "Source Natural Foods Adjusts Valuation Amid Competitive Pharmaceuticals Landscape",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/source-natural-foods-changes-valuation-grade-from-fair-to-attractive-amid-strong-stock-performance-1259474",
        "imagepath": "",
        "date": "2025-03-10 08:00:20",
        "description": "Source Natural Foods & Herbal Supplements has recently undergone a valuation adjustment, reflecting its current standing in the pharmaceuticals and drugs industry. The company exhibits a price-to-earnings (P/E) ratio of 33.87 and an enterprise value to EBITDA ratio of 16.08, indicating its market positioning relative to earnings and operational performance. Additionally, the return on capital employed (ROCE) stands at 23.03%, while the return on equity (ROE) is recorded at 12.62%, showcasing its efficiency in generating profits from investments.\n\nIn comparison to its peers, Source Natural's valuation metrics present a competitive edge. For instance, while Shree Ganesh Remedies is categorized as expensive with a P/E of 32.21, Anuh Pharma and Kopran both maintain attractive valuations with lower P/E ratios of 16.54 and 17.91, respectively. This context highlights Source Natural's relative performance within t..."
      },
      {
        "title": "Source Natural Foods Shows Strong Financial Metrics Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/source-natural-foods-receives-sell-rating-amid-bearish-technical-outlook-despite-positive-financials-1228962",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/SourceNaturalFo_mojoScore_617809.png",
        "date": "2025-03-07 08:04:48",
        "description": "Source Natural Foods & Herbal Supplements has recently adjusted its evaluation, highlighting its strong market position in the pharmaceuticals sector. The company has shown impressive financial metrics, including a high return on equity and low debt-to-equity ratio, alongside consistent profitability over five quarters and significant cash reserves."
      },
      {
        "title": "Source Natural Foods Experiences Technical Indicator Shifts Amid Strong Performance Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/source-natural-foods-herbal-supplements-technical-trend-shifts-from-mildly-bullish-to-mildly-bearish-1110372",
        "imagepath": "",
        "date": "2025-02-25 10:29:46",
        "description": "Source Natural Foods & Herbal Supplements, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting shifts in its technical indicators. The company's current stock price stands at 171.00, showing a notable increase from the previous close of 166.90. Over the past year, Source Natural has demonstrated a robust performance with a stock return of 79.30%, significantly outpacing the Sensex, which recorded a return of just 2.08% during the same period.\n\nIn terms of technical metrics, the MACD indicates a bearish trend on a weekly basis while remaining bullish monthly. The Bollinger Bands also reflect a mildly bearish stance weekly, contrasting with a mildly bullish outlook monthly. The moving averages present a bearish signal on a daily basis, while the KST shows a bearish trend weekly but bullish monthly.\n\nThe company's performance over various time fra..."
      }
    ],
    "total": 60,
    "sid": "446660",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/source-natural-foods-herbal-supplements-446660"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Apr-2025",
      "details": "Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended March 31 2025",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "31-Mar-2025",
      "details": "The Company is hereby intimating the Closure of Trading window with effect from April 1 2025 till 48 hours after the declaration of the Audited Financial Results of the Company for the quarter and year ended on March 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "26-Mar-2025",
      "details": "The Company is pleased to announce its new projects in the Green Energy sector through its new brand Hyenr.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Source Natural Foods Receives Quality Grade Upgrade Amid Strong Growth Metrics

2025-04-01 08:00:03

Source Natural Foods & Herbal Supplements has recently undergone an evaluation revision, reflecting its performance metrics within the pharmaceuticals and drugs industry. The company has demonstrated notable sales growth over the past five years, achieving a rate of 22.39%. Additionally, its EBIT growth during the same period stands at 27.03%, indicating a strong operational performance. Financial stability is further highlighted by the company's average EBIT to interest ratio of 3.45 and a low debt to EBITDA ratio of 0.38, suggesting effective management of financial obligations. The net debt to equity ratio is also minimal at 0.03, showcasing a solid capital structure. Furthermore, the company's return on capital employed (ROCE) and return on equity (ROE) average at 20.17% and 17.97%, respectively, underscoring its efficient use of capital. In comparison to its peers, Source Natural holds an average qua...

Source Natural Foods Faces Valuation Shift Amid Mixed Financial Indicators

2025-03-28 08:04:38

Source Natural Foods & Herbal Supplements has recently adjusted its valuation metrics, reflecting a change in its market position within the Pharmaceuticals & Drugs industry. Key financial indicators, including a high price-to-earnings ratio and a notable return on equity, underscore the complexities of the company's financial landscape.

Source Natural Foods Adjusts Valuation Amid Strong Performance in Pharmaceuticals Sector

2025-03-28 08:00:18

Source Natural Foods & Herbal Supplements has recently undergone a valuation adjustment, reflecting its current standing in the pharmaceuticals and drugs industry. The company, classified as a microcap, has reported a price-to-earnings (P/E) ratio of 45.10 and an enterprise value to EBITDA ratio of 21.49. These metrics indicate a premium valuation compared to some of its peers. In terms of performance, Source Natural has shown notable returns over various periods. Over the past year, the stock has returned 105.51%, significantly outperforming the Sensex, which recorded a return of 6.32%. Additionally, the company has demonstrated strong financial health with a return on capital employed (ROCE) of 23.03% and a return on equity (ROE) of 12.62%. When compared to its peers, Source Natural's valuation metrics stand out, particularly against companies like Shukra Pharma, which has a much higher P/E ratio, and K...

Source Natural Foods Surges Nearly 20% Amid Strong Buying Activity and Market Sentiment

2025-03-27 10:05:07

Source Natural Foods & Herbal Supplements Ltd is witnessing significant buying activity, with the stock surging 19.98% today, notably outperforming the Sensex, which gained only 0.45%. Over the past week, the stock has shown a remarkable increase of 28.08%, while the Sensex rose by 1.68%. This strong performance is part of a two-day consecutive gain, where the stock has returned 26.52%. The stock opened with a notable gap up of 13.56% and reached an intraday high of Rs 183.15. In terms of longer-term performance, Source Natural Foods has delivered a staggering 105.51% return over the past year, compared to the Sensex's 6.35%. However, it is important to note that the stock has experienced a decline of 5.10% year-to-date, while the Sensex has decreased by only 0.65%. The current buying pressure may be attributed to various factors, including market sentiment towards the pharmaceuticals and drugs sector, re...

Source Natural Foods Faces Evaluation Adjustment Amid Mixed Financial Performance Indicators

2025-03-20 08:05:52

Source Natural Foods & Herbal Supplements has recently experienced an evaluation adjustment due to changes in its technical indicators. The company, part of the Pharmaceuticals & Drugs sector, has shown strong financial metrics, including a high return on equity and low debt-to-equity ratio, despite facing recent profit challenges.

Source Natural Foods Reports Positive Financials Amid Bearish Market Conditions

2025-03-13 08:06:10

Source Natural Foods & Herbal Supplements has adjusted its evaluation following positive third-quarter FY24-25 results, including increased cash reserves and net sales. The company maintains strong management efficiency, evidenced by a solid return on equity and low debt levels, despite a slight decline in profits over the past year.

Source Natural Foods Adjusts Valuation Amid Competitive Pharmaceuticals Landscape

2025-03-10 08:00:20

Source Natural Foods & Herbal Supplements has recently undergone a valuation adjustment, reflecting its current standing in the pharmaceuticals and drugs industry. The company exhibits a price-to-earnings (P/E) ratio of 33.87 and an enterprise value to EBITDA ratio of 16.08, indicating its market positioning relative to earnings and operational performance. Additionally, the return on capital employed (ROCE) stands at 23.03%, while the return on equity (ROE) is recorded at 12.62%, showcasing its efficiency in generating profits from investments. In comparison to its peers, Source Natural's valuation metrics present a competitive edge. For instance, while Shree Ganesh Remedies is categorized as expensive with a P/E of 32.21, Anuh Pharma and Kopran both maintain attractive valuations with lower P/E ratios of 16.54 and 17.91, respectively. This context highlights Source Natural's relative performance within t...

Source Natural Foods Shows Strong Financial Metrics Amid Market Challenges

2025-03-07 08:04:48

Source Natural Foods & Herbal Supplements has recently adjusted its evaluation, highlighting its strong market position in the pharmaceuticals sector. The company has shown impressive financial metrics, including a high return on equity and low debt-to-equity ratio, alongside consistent profitability over five quarters and significant cash reserves.

Source Natural Foods Experiences Technical Indicator Shifts Amid Strong Performance Trends

2025-02-25 10:29:46

Source Natural Foods & Herbal Supplements, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting shifts in its technical indicators. The company's current stock price stands at 171.00, showing a notable increase from the previous close of 166.90. Over the past year, Source Natural has demonstrated a robust performance with a stock return of 79.30%, significantly outpacing the Sensex, which recorded a return of just 2.08% during the same period. In terms of technical metrics, the MACD indicates a bearish trend on a weekly basis while remaining bullish monthly. The Bollinger Bands also reflect a mildly bearish stance weekly, contrasting with a mildly bullish outlook monthly. The moving averages present a bearish signal on a daily basis, while the KST shows a bearish trend weekly but bullish monthly. The company's performance over various time fra...

View All News

Announcement

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

07-Apr-2025 | Source : BSE

Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended March 31 2025

Closure of Trading Window

31-Mar-2025 | Source : BSE

The Company is hereby intimating the Closure of Trading window with effect from April 1 2025 till 48 hours after the declaration of the Audited Financial Results of the Company for the quarter and year ended on March 31 2025.